SNDX Company Profile and Key Details

Q: Who are the executives of SNDX?

Sharon KlahreVice President of Investor Relations & CommunicationsDr. Peter Ordentlich B.Sc., Ph.D.Co-Founder & Chief Scientific OfficerDr. Briggs W. Morrison M.D.Pres, Head of R&D and DirectorDr. Ronald M. Evans Ph.D.Co-Founder, Advisor and Chair of Scientific Advisory BoardDr. Michael Downes Ph.D.Co-FounderDr. Briggs W. Morrison M.D., Ph.D.Pres, Head of R&D and DirectorMr. Michael A. Metzger M.B.A.Chief Executive Officer & DirectorDr. Anjali Ganguli Ph.D.Chief Bus. OfficerMr. Keith Alan Goldan CPAChief Financial Officer, Treasurer & Chief Accounting OfficerMr. Steve M. SabusChief Commercial OfficerMr. Luke J. AlbrechtSenior Vice President, Gen. Counsel & Sec.Dr. Catherine Madigan M.D.Chief Medical OfficerMr. Alexander NolteInterim Chief Financial Officer, Principal Accounting Officer & Treasurer

NASDAQ : SNDX

Syndax Pharmaceuticals

$18.35

0.09500069+0.52%

Open: 2:43 PM

55.95

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Syndax Pharmaceuticals, Inc. (SNDX) stock surged +0.52%, trading at $18.35 on NASDAQ, up from the previous close of $18.25. The stock opened at $18.22, fluctuating between $18.16 and $18.55 in the recent session.

Stock Snapshot

18.25

Prev. Close

1.63B

Market Cap

18.155

Day Low

-6.58

P/E Ratio

-2.79

EPS (TTM)

-2.21

Cash Flow per Share

18.22

Open

88.61M

Number of Shares

18.55

Day High

94.89%

Free Float in %

7.64

Book Value

693.87K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 12, 2026	18.05	18.33	17.74	18.25	1.05M
Jun 11, 2026	17.37	18.11	17.31	17.91	1.58M
Jun 10, 2026	17.69	18.05	17.44	17.58	1.39M
Jun 09, 2026	17.30	18.07	17.11	17.69	1.44M
Jun 08, 2026	17.38	17.54	16.66	16.96	2.34M
Jun 05, 2026	18.13	18.13	17.11	17.34	2.7M
Jun 04, 2026	17.10	18.26	16.90	18.02	7.8M
Jun 03, 2026	18.58	18.58	18.10	18.34	1.02M
Jun 01, 2026	19.25	19.57	18.60	18.85	1.46M
May 29, 2026	19.75	19.88	19.43	19.59	861.02K
May 28, 2026	19.58	19.80	19.31	19.75	1.01M
May 27, 2026	19.90	20.43	19.51	19.61	1.05M
May 26, 2026	19.99	20.36	19.66	19.90	850.1K
May 22, 2026	19.78	20.55	19.75	19.94	1.15M
May 21, 2026	20.06	20.14	19.69	19.77	1.2M
May 20, 2026	19.40	20.40	19.40	20.13	994.45K
May 19, 2026	19.52	19.52	19.00	19.36	911.24K
May 18, 2026	20.24	20.83	19.37	19.41	1.33M
May 15, 2026	20.43	20.93	20.16	20.23	1.8M
May 14, 2026	20.90	21.24	20.44	20.55	2.32M

Contact Details

New York City, MA 02451

United States

https://www.syndax.com 781 419 1400

About Company

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.Massachusetts.

Stock Peers

ARGX

-5.42-0.60%

argenx SE$893.52 REGN

0.66+0.11%

Regeneron Pharmaceuticals, Inc.$612.14 UTHR

0.56+0.10%

United Therapeutics Corporation$545.96 MDGL

6.49+1.37%

Madrigal Pharmaceuticals, Inc.$480.77 VRTX

-0.115-0.03%

Vertex Pharmaceuticals Incorporated$444.93 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

-3.575-1.11%

Krystal Biotech, Inc.$317.97 ALNY

-6.54-2.26%

Alnylam Pharmaceuticals, Inc.$282.85 PRAX

18.6+7.50%

Praxis Precision Medicines, Inc.$266.58 LGND

0.97+0.38%

Ligand Pharmaceuticals Incorporated$255.54

Frequently Asked Questions

What is the current Syndax Pharmaceuticals, Inc. (SNDX) stock price?

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stock price is $18.35 in the last trading session. During the trading session, SNDX stock reached the peak price of $18.55 while $18.16 was the lowest point it dropped to. The percentage change in SNDX stock occurred in the recent session was 0.52% while the dollar amount for the price change in SNDX stock was $0.10.

SNDX's industry and sector of operation?

The NASDAQ listed SNDX is part of Biotechnology industry that operates in the broader Healthcare sector. Syndax Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of SNDX?

Sharon Klahre
Vice President of Investor Relations & Communications
Dr. Peter Ordentlich B.Sc., Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Briggs W. Morrison M.D.
Pres, Head of R&D and Director
Dr. Ronald M. Evans Ph.D.
Co-Founder, Advisor and Chair of Scientific Advisory Board
Dr. Michael Downes Ph.D.
Co-Founder
Dr. Briggs W. Morrison M.D., Ph.D.
Pres, Head of R&D and Director
Mr. Michael A. Metzger M.B.A.
Chief Executive Officer & Director
Dr. Anjali Ganguli Ph.D.
Chief Bus. Officer
Mr. Keith Alan Goldan CPA
Chief Financial Officer, Treasurer & Chief Accounting Officer
Mr. Steve M. Sabus
Chief Commercial Officer
Mr. Luke J. Albrecht
Senior Vice President, Gen. Counsel & Sec.
Dr. Catherine Madigan M.D.
Chief Medical Officer
Mr. Alexander Nolte
Interim Chief Financial Officer, Principal Accounting Officer & Treasurer

How SNDX did perform over past 52-week?

SNDX's closing price is 112.58% higher than its 52-week low of $8.59 where as its distance from 52-week high of $25.59 is -28.68%.

How many employees does SNDX have?

Number of SNDX employees currently stands at 270.

Link for SNDX official website?

Official Website of SNDX is: https://www.syndax.com

How do I contact SNDX?

SNDX could be contacted at phone 781 419 1400 and can also be accessed through its website. SNDX operates from 35 Gatehouse Drive, New York City, MA 02451, United States.

How many shares of SNDX are traded daily?

SNDX stock volume for the day was 693.87K shares. The average number of SNDX shares traded daily for last 3 months was 1.66M.

What is the market cap of SNDX currently?

The market value of SNDX currently stands at $1.63B with its latest stock price at $18.35 and 88.61M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	270
Beta	0.41
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	270
Beta	0.41
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

SNDX Company Profile and Key Details

Syndax Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics